Market Tracker

11/28 2:15pm ET

Nektar Therapeutics (NASDAQ:NKTR)

16.67
Data as of 12:59pm ET
 -0.04 / -0.24%
Today’s Change
10.10
Today|||52-Week Range
17.28
+46.87%
Year-to-Date

Today’s Trading

Previous close16.71
Today’s open16.67
Day’s range16.53 - 17.28
Volume1,511,304
Average volume (3 months)1,350,723
Market cap$2.1B
Dividend yield--
Data as of 12:59pm ET, 11/28/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+68.65%
Earnings growth (next 5 years)+53.58%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DYAXDyax Corp+0.13+0.93%
ABCOAdvisory Board Co-0.01-0.02%
INCRINC Research Holding...+0.39+1.63%
KERXKeryx Biopharmaceuti...+0.01+0.06%
Data as of 12:59pm ET, 11/28/2014

Financials

Next reporting dateFebruary 25, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts